Syntax Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$410K Sell
5,768
-673
-10% -$50.3K 0.36% 36
2023
Q2
$496K Sell
6,441
-703
-10% -$54.4K 0.4% 33
2023
Q1
$537K Buy
7,144
+539
+8% +$40.1K 0.41% 28
2022
Q4
$520K Sell
6,605
-392
-6% -$29.4K 0.43% 18
2022
Q3
$492K Buy
6,997
+326
+5% +$25.6K 0.42% 23
2022
Q2
$535K Buy
6,671
+61
+0.9% +$4.77K 0.45% 16
2022
Q1
$501K Sell
6,610
-332
-5% -$26.3K 0.42% 33
2021
Q4
$592K Buy
+6,942
New +$542K 0.44% 14

Other funds holding CL

Syntax Advisors's CL Position: Q3 2023 in Review

Syntax Advisors reduced its Colgate-Palmolive (CL) stake by 10% in Q3 2023, selling an estimated $50.3K and leaving 5,768 shares worth $410K. The position accounts for 0.36% of the portfolio, ranked #36.

Syntax Advisors first reported a position in CL in Q4 2021 and has held it in 8 quarters since. The position peaked at $592K in Q4 2021. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Syntax Advisors held 5,768 shares of Colgate-Palmolive worth $410K as of Q3 2023.
  • Syntax Advisors sold 673 Colgate-Palmolive shares in Q3 2023, an estimated $50.3K.
  • Colgate-Palmolive made up 0.36% of Syntax Advisors's portfolio in Q3 2023, its #36 holding.
  • Syntax Advisors first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Colgate-Palmolive position peaked at $592K in Q4 2021.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.